

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding and treating... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1427/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1427" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding and treating chronic granulomatous disease" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding and treating chronic granulomatous disease.">
            <meta name="og:description" content="Read the latest article version by Andrew Gennery, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12735">
            <meta name="article-id" content="11789">
            <meta name="dc.title" content="Recent advances in understanding and treating chronic granulomatous disease">
            <meta name="dc.description" content="A number of recent advances have been made in the epidemiology and treatment of chronic granulomatous disease. Several reports from developing regions describe the presentations and progress of local populations, highlighting complications due to Bacillus Calmette&ndash;Gu&amp;eacute;rin vaccination. A number of new reports describe complications of chronic granulomatous disease in adult patients, as more survivors reach adulthood. The complications experienced by X-linked carriers are particularly highlighted in three new reports, confirming that infection and inflammatory or autoimmune conditions are more common and severe than previously recognised. Finally, definitive treatment with haematopoietic stem cell transplantation and gene therapy is reviewed.">
            <meta name="dc.subject" content="chronic granulomatous disease, haematopoietic stem cell transplantation, gene therapy, inflammatory bowel disease, X-linked carrier disease">
            <meta name="dc.creator" content="Gennery, Andrew">
            <meta name="dc.date" content="2017/08/11">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11789.1">
            <meta name="dc.source" content="F1000Research 2017 6:1427">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="chronic granulomatous disease">
            <meta name="prism.keyword" content="haematopoietic stem cell transplantation">
            <meta name="prism.keyword" content="gene therapy">
            <meta name="prism.keyword" content="inflammatory bowel disease">
            <meta name="prism.keyword" content="X-linked carrier disease">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/08/11">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1427">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11789.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1427">
            <meta name="citation_title" content="Recent advances in understanding and treating chronic granulomatous disease">
            <meta name="citation_abstract" content="A number of recent advances have been made in the epidemiology and treatment of chronic granulomatous disease. Several reports from developing regions describe the presentations and progress of local populations, highlighting complications due to Bacillus Calmette&ndash;Gu&amp;eacute;rin vaccination. A number of new reports describe complications of chronic granulomatous disease in adult patients, as more survivors reach adulthood. The complications experienced by X-linked carriers are particularly highlighted in three new reports, confirming that infection and inflammatory or autoimmune conditions are more common and severe than previously recognised. Finally, definitive treatment with haematopoietic stem cell transplantation and gene therapy is reviewed.">
            <meta name="citation_description" content="A number of recent advances have been made in the epidemiology and treatment of chronic granulomatous disease. Several reports from developing regions describe the presentations and progress of local populations, highlighting complications due to Bacillus Calmette&ndash;Gu&amp;eacute;rin vaccination. A number of new reports describe complications of chronic granulomatous disease in adult patients, as more survivors reach adulthood. The complications experienced by X-linked carriers are particularly highlighted in three new reports, confirming that infection and inflammatory or autoimmune conditions are more common and severe than previously recognised. Finally, definitive treatment with haematopoietic stem cell transplantation and gene therapy is reviewed.">
            <meta name="citation_keywords" content="chronic granulomatous disease, haematopoietic stem cell transplantation, gene therapy, inflammatory bowel disease, X-linked carrier disease">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Andrew Gennery">
            <meta name="citation_author_institution" content="Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK">
            <meta name="citation_author_institution" content="Paediatric Immunology and Haematopoietic Stem Cell Transplantation, Great North Childrens&rsquo; Hospital, Newcastle upon Tyne, UK">
            <meta name="citation_publication_date" content="2017/08/11">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1427">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11789.1">
            <meta name="citation_firstpage" content="1427">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1427/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1427.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12735 /> <input type=hidden id=articleId name=articleId value=11789 /> <input type=hidden id=xmlUrl value="/articles/6-1427/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1427-v1.xml"> <input type=hidden id=article_uuid value=e51ccc91-44fa-4a35-ac8b-159fe8721cfd /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding and treating chronic granulomatous disease"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11789.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11789.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1427"
  },
  "headline": "Recent advances in understanding and treating chronic granulomatous disease",
  "datePublished": "2017-08-11T10:19:26",
  "dateModified": "2017-08-11T10:19:26",
  "author": [
    {
      "@type": "Person",
      "name": "Andrew Gennery"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "A number of recent advances have been made in the epidemiology and treatment of chronic granulomatous disease. Several reports from developing regions describe the presentations and progress of local populations, highlighting complications due to Bacillus Calmette&ndash;Gu&amp;eacute;rin vaccination. A number of new reports describe complications of chronic granulomatous disease in adult patients, as more survivors reach adulthood. The complications experienced by X-linked carriers are particularly highlighted in three new reports, confirming that infection and inflammatory or autoimmune conditions are more common and severe than previously recognised. Finally, definitive treatment with haematopoietic stem cell transplantation and gene therapy is reviewed."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1427.html",
            "name": "Recent advances in understanding and treating chronic granulomatous..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding and treating chronic granulomatous... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12735 data-id=11789 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11789.1" data-recommended="" data-doi="10.12688/f1000research.11789.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1427/v1/pdf?article_uuid=e51ccc91-44fa-4a35-ac8b-159fe8721cfd" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11789-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11789-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11789-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Gennery A. Recent advances in understanding and treating chronic granulomatous disease [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1427 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11789.1" target=_blank>https://doi.org/10.12688/f1000research.11789.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11789-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11789 id=track-article-signin-11789 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11789?target=/articles/6-1427.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12735 /> <input name=articleId type=hidden value=11789 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding and treating chronic granulomatous disease</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:a.r.gennery@ncl.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Andrew Gennery</span></a><a href="https://orcid.org/0000-0002-6218-1324" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6218-1324</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:a.r.gennery@ncl.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Andrew Gennery</span></a><a href="http://orcid.org/0000-0002-6218-1324" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6218-1324</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 11 Aug 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11789.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Paediatric Immunology and Haematopoietic Stem Cell Transplantation, Great North Childrens&rsquo; Hospital, Newcastle upon Tyne, UK<br/> <sup>2</sup> Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK<br/> <p> <div class=margin-bottom> Andrew Gennery <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25044-24941></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25047-24944></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25045-24942></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25046-24943></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> A number of recent advances have been made in the epidemiology and treatment of chronic granulomatous disease. Several reports from developing regions describe the presentations and progress of local populations, highlighting complications due to Bacillus Calmette–Gu&eacute;rin vaccination. A number of new reports describe complications of chronic granulomatous disease in adult patients, as more survivors reach adulthood. The complications experienced by X-linked carriers are particularly highlighted in three new reports, confirming that infection and inflammatory or autoimmune conditions are more common and severe than previously recognised. Finally, definitive treatment with haematopoietic stem cell transplantation and gene therapy is reviewed. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> chronic granulomatous disease, haematopoietic stem cell transplantation, gene therapy, inflammatory bowel disease, X-linked carrier disease </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Andrew Gennery (<a href="mailto:a.r.gennery@ncl.ac.uk">a.r.gennery@ncl.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Andrew Gennery </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The author declares that he has no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Gennery A. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Gennery A. Recent advances in understanding and treating chronic granulomatous disease [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1427 (<a href="https://doi.org/10.12688/f1000research.11789.1" target=_blank>https://doi.org/10.12688/f1000research.11789.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 11 Aug 2017, <b>6</b>(F1000 Faculty Rev):1427 (<a href="https://doi.org/10.12688/f1000research.11789.1" target=_blank>https://doi.org/10.12688/f1000research.11789.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 11 Aug 2017, <b>6</b>(F1000 Faculty Rev):1427 (<a href="https://doi.org/10.12688/f1000research.11789.1" target=_blank>https://doi.org/10.12688/f1000research.11789.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d95813e149>Introduction</h2><p class="" id=d95813e152>Chronic granulomatous disease (CGD) results from an inherited defect in one of six components of the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzyme complex, responsible for generating reactive oxygen species (ROS) released during the phagocyte respiratory burst to eliminate ingested micro-organisms. Two membrane-bound cytochrome heterodimer components—gp91<sup>phox</sup> and p22<sup>phox</sup> (encoded by <i>CYBB</i> and CYBA respectively)—embedded within the membrane of lysosomes come together with the four cytosolic components—p47<sup>phox</sup>, p67<sup> phox</sup>, p40<sup>phox</sup>, and <i>RAC2</i> (encoded by <i>NCF1</i>, <i>NCF2</i>, <i>NCF4</i> and <i>RAC2</i> respectively)—to activate NADPH to produce hydrogen peroxide. Transfer of electrons from the NADPH complex to molecular oxygen creates a negative charge within the phago-lysosome. This enables influx of potassium through calcium-activated potassium channels. Thus, microbial killing likely occurs through direct action of ROS upon microbes as well as super oxidase-mediated activation of additional killing pathways.</p><p class="" id=d95813e189>In out-bred populations, X-linked disease due to mutations in <i>CYBB</i> is most common. There are numerous clinical manifestations, but the hallmark is severe invasive, bacterial or fungal infection, frequently due to catalase-positive organisms or <i>Aspergillus</i> species. However, inflammation plays an important role in the pathogenesis and sequalae of the disease. Much information regarding the epidemiology, clinical manifestations, treatment approaches and outcome of patients with CGD has been gathered over the years, since the first description by Robert Good in 1957<sup><a href="#ref-1">1</a></sup>. This review will focus on newly published information over the past couple of years.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d95813e205>Epidemiology</h2><div class=section><a name=d95813e208 class=n-a></a><h3 class=section-title>Chronic granulomatous disease in developing regions</h3><p class="" id=d95813e213>To date, most information regarding presentation and outcome of patients with CGD has come from developed countries<sup><a href="#ref-2">2</a>–<a href="#ref-9">9</a></sup>. However, the genetic diversity and presentation of primary immunodeficiencies are dependent on the specific population and environmental influence respectively, and published information to date does not reflect the disease in other geographical areas of the world. Recent publications from India, Central and Latin America, Africa and the Middle East and China have given a wider perspective on the disease. Although ascertainment is incomplete and shows bias, some conclusions can be drawn. The Chinese cohort of 48 patients shows some interesting trends<sup><a href="#ref-10">10</a></sup>, confirming observations from a previous Chinese study<sup><a href="#ref-11">11</a></sup>. Most patients had X-linked CGD, confirming the predominance of X-linked disease worldwide in non-consanguineous populations. Most diagnoses were after 2010 and presumably this was due to greater awareness of the disease. All were diagnosed in early childhood. There was a high mortality (22%), and deaths were due to infection. Complications due to Bacillus Calmette–Guérin (BCG) vaccination were particularly prevalent. Inflammatory complications were not reported, and there were no adults in the cohort. A number of mutations were reported, although in previous series from China the accuracy of the data has been questioned<sup><a href="#ref-11">11</a>,<a href="#ref-12">12</a></sup>.</p><p class="" id=d95813e238>Two Indian CGD patient cohorts have been reported recently. In one, there was a similar incidence of X-linked and autosomal recessive (AR) CGD<sup><a href="#ref-13">13</a></sup>. Infections were the predominating clinical problem, although significant BCG infections were rare. All patients were diagnosed in early childhood and there was a significant mortality of 29%. Most cases were diagnosed in the 3 years before the report was published. The second cohort compared 21 patients with the same genetic deletion in p47<sup>phox</sup> (a two-base pair GT dinucleotide deletion at the beginning of exon 2 in <i>NCF1</i>, the most common defect in p47<sup>phox</sup>-defective CGD). All patients were diagnosed in early childhood, and infection was the most significant clinical problem. Mortality was high at 24%<sup><a href="#ref-14">14</a></sup>.</p><p class="" id=d95813e258>Three Mediterranean cohorts—from Egypt, Tunisia and Israel—have been published recently. The Egyptian cohort of 28 patients showed a predominance of AR-CGD (82%), mainly due to mutations in <i>CYBA</i><sup><a href="#ref-15">15</a></sup>. Whilst infection was the most common presentation, BCG complications were less common and inflammatory complications were reported in this paediatric cohort. Additionally, the study showed the value of intracellular staining of NADPH components using specific monoclonal antibodies followed by flow cytometric analysis in aiding the diagnosis. The Tunisian study reported on 11 patients from contiguous regions within western Tunisia, with a unique mutation in <i>NCF2</i>, and demonstrated a founder effect<sup><a href="#ref-16">16</a></sup>. All patients presented in childhood with infection, a high incidence of tuberculosis and a mortality of 80%. Other CGD cases in the country demonstrate different forms of AR-CGD. This study highlights the importance of local knowledge of a disease; similar founder effects have been found in populations in Oman<sup><a href="#ref-17">17</a></sup> and Korea<sup><a href="#ref-18">18</a></sup> and in Kavkazi Jews<sup><a href="#ref-19">19</a></sup>. An Israeli study of 84 patients looked at a mixed population of Jewish and Arab patients<sup><a href="#ref-20">20</a></sup>. X-linked disease was more common in the Jewish populations, and AR-CGD was found predominantly in consanguineous Arab and Jewish populations. Severity of disease was related to the degree of residual oxidative burst, confirming a previous report<sup><a href="#ref-21">21</a></sup>. Most patients presented early in childhood with infection; mycobacterial infection did not predominate in this series. Granulomatous inflammation was commonly reported. A quarter of patients received haematopoietic stem cell transplantation. Overall survival was good, and mortality since 2008 was 2%, reflecting improvements in medical management.</p><p class="" id=d95813e295>A Mexican series describes a cohort of 27 patients with CGD, amongst a larger primary immunodeficiency disorder population<sup><a href="#ref-22">22</a></sup>. The mortality was 33%. Disappointingly, survival was no different in patients diagnosed before or after 2001, and it dropped dramatically after 10 years of age. The Latin American Society for Immunodeficiencies studied a cohort of 71 patients from five countries, including Mexico<sup><a href="#ref-23">23</a></sup>. X-linked CGD was most commonly represented (75%), followed by defects in p47<sup>phox</sup> (23%). Pulmonary infectious presentation was most common; BCG complications occurred in 30% (predominantly those with X-linked disease). Some patients had undergone haematopoietic stem cell transplantation, whilst others were receiving prophylaxis. There were no recorded deaths in the cohort during the study period.</p><p class="" id=d95813e310>Several observations can be made from these studies. Firstly, they confirm that whilst X-linked CGD is found most commonly in out-bred populations, AR disease is more common in areas with high consanguinity, and specific founder effects are evident in particular populations. Secondly, infectious issues predominate, in a pattern and with micro-organisms that are commonly seen in developed countries. The exceptions to this—tuberculosis or infectious complications secondary to BCG vaccination—make up a significant proportion of the infections reported in these studies. The high morbidity associated with BCG vaccination suggests that screening for CGD could be considered in these populations before BCG is administered. Mycobacterial infection is a recognised complication of CGD, although in a published large multi-centre series, the isolates were BCG or <i>Mycobacterium tuberculosis</i> rather than <i>Mycobacterium leperae</i> or environmental mycobacteria<sup><a href="#ref-24">24</a></sup>. In this survey, 24% of patients presented solely with mycobacterial infection. Thirdly, whilst infections were a predominant clinical problem, inflammatory complications were rarely reported. Whether this was due to ascertainment bias, a lack of recognition or a high, infectious early mortality is not clear. Despite tremendous advances in medical care within developed countries, CGD continues to have a high mortality in less advantaged countries. Greater awareness amongst physicians in these regions may help with earlier recognition and treatment, and registry data would further map the genetic pattern and clinical complications.</p></div><div class=section><a name=d95813e324 class=n-a></a><h3 class=section-title>Chronic granulomatous disease in adults</h3><p class="" id=d95813e329>A number of new reports have given further information on adult patients with CGD. Adult patients fall into three categories: those diagnosed as children and surviving to adulthood<sup><a href="#ref-25">25</a></sup>, those who are symptomatic in childhood but are diagnosed only as adults<sup><a href="#ref-26">26</a></sup> and those with mild disease who present for the first time as adults<sup><a href="#ref-26">26</a></sup>. A survey of the French CGD cohort reported on 80 adult patients with CGD who were all diagnosed by the age of 16 years and thus gives insight into the clinical course of patients in a developed healthcare system, diagnosed in the modern era when chemo-prophylaxis with antibacterial and antifungal agents was employed. Several important findings were presented. Firstly, despite appropriate prophylaxis, infections occurred every 3.75 patient-years. The frequency of infections in adults was no different to those in children. Furthermore, 10 patients (12.5%) died in adulthood, almost all from infectious causes, confirming that infection is the leading cause of death in CGD, even in adults receiving appropriate prophylaxis. The most common pathogens remained <i>Staphylococcus aureus</i> and <i>Aspergillus</i> species. Secondly, inflammatory and autoimmune complications were extremely common, affecting almost 90% of patients. These complications were as common in adulthood as in childhood, but the first event occurred at a later age than the first infectious presentation, perhaps explaining why inflammatory and autoimmune manifestations were under-reported in cohorts from developing regions. Thirdly, there was a significant burden of chronic disease in the adult cohort, including short stature, particularly in those receiving corticosteroids in adolescence. Additional findings included low body weight, chronic dyspnoea, often associated with radiological changes, and gastrointestinal complications. The findings in this report emphasise that the CGD disease burden transfers and may deteriorate during adulthood and, though not explicitly stated, likely negatively impacts quality of life. Furthermore, despite modern management, there is an ongoing mortality associated with the disease.</p><p class="" id=d95813e350>A separately published study of the same adult French CGD cohort specifically examined respiratory complications<sup><a href="#ref-27">27</a></sup>. Nine (13%) of 67 patients died, predominantly from <i>Aspergillus</i> species infection. Infective or inflammatory respiratory complications were common and were found more frequently than in childhood, despite appropriate antimicrobial chemo-prophylaxis. Treatment of these complications was complicated and often was prolonged for more than 6 months and frequently involved lengthy hospitalisation and invasive, sometimes multiple therapies. Inflammatory respiratory complications occurred in more than 25% of patients, and non-infectious complications were more likely to be persistent. Several issues are raised by this study. It gives insight into the natural history of CGD, modified through therapeutic intervention, and particularly highlights patients presenting with less severe disease, modified by genetics or environmental factors or both. Additionally, it raises awareness of risks and benefits of earlier intervention in the disease course. Finally, it demonstrates the challenge to adult physicians, managing patients with potentially unfamiliar “paediatric” diseases.</p><p class="" id=d95813e360>Two reports describe patients presenting with AR-CGD in adulthood. Colin de Verdière and colleagues describe two unrelated adults who presented with respiratory symptoms due to unusual infectious micro-organisms (<i>Aspergillus fumigatus</i> and <i>Pantoea</i> species in one and <i>Nocardia</i> species in the other)<sup><a href="#ref-28">28</a></sup>. Both had earlier presented in early adulthood with inflammatory bowel disease. A report from Iran describes a 40-year-old man with a history of granulomatous lung lesions and recurrent skin and soft tissue abscesses who presented with respiratory symptoms<sup><a href="#ref-29">29</a></sup>. Histological examination demonstrated lymphocytic bronchiolitis, and subsequently a diagnosis of CGD was confirmed.</p><p class="" id=d95813e380>These cases demonstrate that vigilance is required when confronted with adult patients presenting with unusual infections, especially if they are due to catalase-positive micro-organisms which are specifically associated with CGD<sup><a href="#ref-30">30</a></sup> or if other infectious or inflammatory features are evident in the history; it is likely that CGD in adults is more common than currently recognised.</p><p class="" id=d95813e388>Whilst defective NADPH function is generally associated with unfavourable sequelae, emerging evidence suggests that mutations in <i>CYBB</i> and <i>NCF1</i> may play a protective role in inflammatory arterial disease. Enhanced production of pro-inflammatory cytokines by defective myeloid cells in CGD patients contributes to the exuberant inflammatory response in response to, or independent of, infection. Excess inflammation has also been implicated in the pathogenesis of cardiovascular disease and atherosclerosis, particularly associated with increased ROS generated by the NADPH oxidase (NOX) protein family, NOX2, NOX1, and NOX4. NOX2 contributes to the vascular endothelial cell response to nitric oxide and has increased expression in the atherosclerotic plaque in inflammatory vascular disease. NOX2 is also expressed in platelets, inducing platelet aggregation and thrombosis. Reduced NOX activity may diminish vascular inflammation and platelet aggregation and so decrease susceptibility to atherosclerosis.</p><p class="" id=d95813e397>A recent study provides evidence that reduced NOX activity in CGD patients diminishes the risk of atherosclerosis<sup><a href="#ref-31">31</a></sup>. In a study of 41 patients with X-linked or p47<sup>phox</sup>-deficient CGD, who had increased risk factors for arterial inflammation, including hypertension, oxidised low-density lipoprotein, and low high-density lipoprotein, a significantly lower internal carotid artery wall volume was found compared with healthy control subjects although coronary arterial calcification was similar in the two groups<sup><a href="#ref-31">31</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d95813e415>Inflammatory bowel disease</h2><p class="" id=d95813e418>New information has recently been published in relation to clinical presentation of patients with CGD and, in particular, in relation to gastrointestinal symptoms. A study of 93 patients followed at the National Institutes of Health (NIH) compared patients with inflammatory bowel disease with those without disease, specifically looking for associations with previously published inflammatory bowel disease risk single nucleotide polymorphism genotypes<sup><a href="#ref-32">32</a></sup>. Common inflammatory bowel disease risk alleles were associated with CGD inflammatory bowel disease, but the association was less strong than for that in paediatric patients with Crohn’s disease, confirming that reduced superoxide production is an independent risk factor for development of inflammatory bowel disease.</p><p class="" id=d95813e425>A small study of eight asymptomatic patients sought to evaluate whether faecal calprotectin predicted sub-clinical inflammatory bowel disease. Only one patient had raised values, who subsequently developed colitis<sup><a href="#ref-33">33</a></sup>. Further studies are required to confirm this observation. A retrospective study of 78 patients in whom investigation was indicated documented endoscopic findings<sup><a href="#ref-34">34</a></sup>. The study concluded that investigation was useful to diagnose inflammatory bowel disease and differentiate CGD-associated inflammatory bowel disease from other causes of colitis. Additionally, the severity of disease could be determined, and response to treatment determined.</p><p class="" id=d95813e436>An interesting study examined the role of gastrointestinal microbiota in pathogenesis of colitis in p47<sup>phox−/−</sup> mice<sup><a href="#ref-35">35</a></sup>, suggesting that the signature of the microbiome played a significant role in resistance to, or development of, dextran sodium sulfate-induced colitis. These data support the concept that intestinal bacteria play a significant role in the development and maintenance of colitis, although human studies are required to confirm this. Intriguingly, haematopoietic stem transplantation to restore p47<sup>phox</sup> function failed to resolve colitis in the mouse model, findings not observed in patients who have been transplanted. Whether this is a species-specific finding or instead suggests non-haematopoietic cell production of ROS needs further exploration.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d95813e452>Inflammation in chronic granulomatous disease</h2><p class="" id=d95813e455>A number of important studies have recently been published which add information to our understanding of the development of inflammatory complications in CGD. Patients experience symptoms, which overlap with those experienced by patients with systemic lupus erythematosus (SLE). Neutrophil-derived proteolytic enzymes and reactive intermediate oxygen species are implicated in inflammatory responses through interaction with innate and adaptive immune pathways. Neutrophil extracellular traps (NETs) are DNA structures formed because of chromatin decondensation and spreading. Numerous proteins that have bactericidal activity and are able to destroy virulence factors, including histones, elastase, myeloperoxidase, cathepsin G, and lactoferrin, adhere to NETs. Formation of NETs is implicated in autoimmunity through opsonisation by autoantibodies leading to plasmacytoid dendritic cell–induced interferon-alpha (IFN-α) synthesis and inflammasome activation. Ribonucleoprotein-containing immune complexes, which are abundant in SLE, can induce NET formation, as can low-density granulocytes, a pro-inflammatory neutrophil subset present in individuals with SLE. Other inducers of NETs include pathogens and cytokines such as interleukin 1 beta (IL-1β). Production of ROS by NOX-dependent pathways is necessary for NET formation. A study by Lood and colleagues demonstrated the ability of mitochondrial ROS to stimulate NET formation in the pro-inflammatory low-density granulocytes in lupus and CGD subjects<sup><a href="#ref-36">36</a></sup>. Additionally, they demonstrated that the release of oxidised mitochondrial DNA with potent pro-inflammatory and IFN-driven properties was able to generate NETs even in CGD patients with reduced or absent functional NOX. This study indicates that a key pathway of innate immune activation predisposing to autoimmunity in patients with CGD is similar to that of patients with SLE. That pathway is mitochondrial ROS-driven NET formation in low-density granulocytes, which stimulates externalisation of pro-inflammatory oxidised mitochondrial DNA with consequent activation of stimulator of IFN genes (STING) and Toll-like receptor (TLR)-dependent type I IFN synthesis.</p><p class="" id=d95813e462>The importance of these findings is emphasised by a study by Weisser and colleagues, who demonstrated that persistent chronic inflammation in patients with CGD leads to haematopoietic proliferative stress and a decrease in the functional activity of haematopoietic stem cells<sup><a href="#ref-37">37</a></sup>. Quality and quantity of haematopoietic stem cells are affected, leading to a low proportion of primitive haematopoietic stem or progenitor cells in bone marrow from patients with X-linked CGD, which has implications for those undergoing autologous gene therapy. Treatment directed at this pathway may reduce the autoimmune predisposition as well as improve haematopoietic stem cell mobilisation for gene therapy.</p><p class="" id=d95813e469>Macrophage activation syndrome is caused by excessive activation and proliferation of well-differentiated macrophages and is synonymous with haemophagocytic lymphohistiocytosis (HLH), a potentially life-threatening hyper-inflammatory syndrome. Clinical features include persistent fever, lymphadenopathy, hepatosplenomegaly, cytopenia, raised liver cell enzymes, and coagulopathy. Most commonly associated with hereditary HLH syndromes, it has been described in a variety of other primary immunodeficiencies. A recent survey found that over 30% of non-hereditary HLH syndrome cases were associated with CGD<sup><a href="#ref-38">38</a></sup>. Overall survival for this sub-group was good, and most received treatment with immunoglobulin and cortico-steroids rather than one of the standard HLH protocols. The failure to identify HLH in other neutrophil disorders may suggest a genetic predisposition in CGD patients, associated with a hyper-inflammatory phenotype, rather than an infectious trigger.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d95813e479>X-linked carrier disease</h2><p class="" id=d95813e482>Female carriers of X-linked AR disorders are generally considered to be clinically unaffected by the defective gene. In X-linked CGD, female carriers possess a mutated gene on one X chromosome and a normal copy on the other X chromosome and, subsequent to lyonisation, have two phagocyte populations: one which is gp91<sup>phox</sup>-positive and one which is gp91<sup>phox</sup>-negative. Early in foetal development, random X chromosome inactivation of haematopoietic precursor cells may lead to two unequal populations. It is unclear whether the proportion of normal to affected cells can change over time. For many years, it has been acknowledged that female carriers of X-linked CGD may experience discoid lupus erythematosis-like lesions<sup><a href="#ref-39">39</a></sup>. However, it is increasingly evident that carriers may display clinical manifestations similar to those of patients with X-linked CGD, which may significantly impact health. A recent study documented wide-ranging autoimmune and inflammatory symptoms in the UK cohort of 81 X-linked CGD carriers, similar to clinical presentations of CGD patients. Specifically, 25% of carriers met at least four of the American Rheumatology Association SLE diagnostic criteria, although only 18% had been diagnosed with a lupus-like disorder<sup><a href="#ref-40">40</a></sup>. Seventy-nine percent of subjects reported skin symptoms, most frequently photosensitivity. Additionally, gastrointestinal symptoms were reported by 49% of carriers, most frequently abdominal pain and diarrhoea, although most did not have a defined diagnosis. Histological features of Crohn’s disease were reported in two carriers, and colitis was reported in one. Colitis in an index CGD case correlated with symptoms in the related carriers. For those carriers who reported joint symptoms, episodic inflammation, pain and redness were common symptoms, associated with extreme fatigue. In a separate study of the same cohort, fatigue was associated with raised serum levels of IL-8<sup><a href="#ref-41">41</a></sup>.</p><p class="" id=d95813e503>Following this, the NIH published findings on 92 subjects from their carrier cohort<sup><a href="#ref-42">42</a></sup>. The percentage of residual respiratory burst was unrelated to age of the subject, but a low percentage of dihydrorhodamine oxidation (median of 8%) correlated with clinical features. In contrast, there was no association of degree of lyonisation with autoimmunity, suggesting that the risk was associated with carrier status alone. Limited data from this study suggested a strong correlation of the degree of lyonisation in sisters but not in mother-daughter pairs.</p><p class="" id=d95813e510>Hauck and colleagues reported on two unrelated female carriers who had non-random X-chromosome inactivation with neutrophil oxidative bursts of 11% and 30% respectively<sup><a href="#ref-43">43</a></sup>. Both developed severe fistulating Crohn’s-like inflammatory bowel disease with histo-pathological features similar to those found in patients with CGD-colitis. The second patient underwent allogeneic haematopoietic stem cell transplantation and had complete remission of bowel symptoms at 16 months of follow-up. A 53-year-old Australian women developed refractory pneumonia from which lobectomy tissue grew <i>Burkholderia cepacia</i>. Histopathological examination revealed diffuse pneumonic consolidation with suppurative, necrotising granulomata. An immunological assessment demonstrated reduced neutrophil function due to extreme lyonisation with only 3% normally functioning neutrophils. A pathogenic mutation in <i>CYBB</i> was found on sequencing, confirming her status as a symptomatic carrier of X-linked CGD; a positive family history was subsequently elicited<sup><a href="#ref-44">44</a></sup>.</p><p class="" id=d95813e527>These studies are important because they demonstrate that X-linked carriers experience significant symptoms, many of which have been under-recognised by medical professionals and many of which can be addressed. Fatigue is a particular issue, which appears to have an inflammatory basis. Furthermore, some individuals have symptoms as severe as those of CGD patients, often associated with extreme lyonisation, and definitive therapy has a role in these individuals. Finally, they raise doubt about the prudence of using carriers as sibling or parental donors for patients with CGD.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d95813e534>New treatment strategies</h2><div class=section><a name=d95813e537 class=n-a></a><h3 class=section-title>Anti-inflammatory therapy</h3><p class="" id=d95813e542>Inflammatory complications, particularly colitis, are amongst the most challenging symptoms to address in patients with CGD, as treatment with immunosuppressive agents might increase the risk of infection<sup><a href="#ref-45">45</a></sup>. By recognising the role of pro-inflammatory cytokines such as IL-1β in the inflammatory process, targeted blockade may offer a focused treatment. However, in contra-distinction to a previous report suggesting that treatment with the recombinant IL-1 receptor targeted antagonist, anakinra, offered therapeutic benefit<sup><a href="#ref-46">46</a></sup>, treatment of five patients with severe refractory colitis led to marginal or no benefit<sup><a href="#ref-47">47</a></sup>. However, despite treatment for at least 3 months, no significant infectious complications were encountered. Further studies are required to determine whether IL-1 receptor blockade offers benefit for any group of patients with CGD.</p><p class="" id=d95813e557>To pursue that idea further, a more recent study focused on ways to counter the defect in autophagy and associated inflammasome activation evident in NOX defective mononuclear phagocytes<sup><a href="#ref-48">48</a></sup>. Interestingly, even patients without inflammatory manifestations had a reliable inflammatory phenotype characterised by an increase in non-classic and intermediate monocytes, a pro-inflammatory state of mononuclear phagocytes with increased IL-1β and tumour necrosis factor alpha (TNFα) content, a bias of CD4<sup>+</sup> T lymphocytes toward a TH17 phenotype, and increased in IL-17A–secreting neutrophils. <i>In vitro</i> studies of mononuclear phagocytes from patients with clinical inflammation, treated <i>in vitro</i> with the mechanistic target of rapamycin (mTOR) inhibitor, rapamycin, to restore autophagy, showed reduced basal TNFα production and secretion and suppression of IL-1β, IL-6 and IL-23 secretion by lipopolysaccharide-primed monocytes, with impaired TH17 switching<sup><a href="#ref-48">48</a></sup>. Of note, inhibition of the IL-1 receptor with anakinra, enhanced the inhibitory effect of rapamycin on phagocyte IL-1β secretion. These <i>in vitro</i> data suggest that a combination of rapamycin with anakinra could be considered for patients with CGD with inflammatory complications.</p><p class="" id=d95813e581>A single case reports the use of the IL-23 antagonist ustekinumab to treat longstanding treatment-recalcitrant colitis<sup><a href="#ref-49">49</a></sup>. There was significant symptomatic improvement, but the patient developed probable severe infection necessitating discontinuation of ustekinumab, after which symptoms returned<sup><a href="#ref-49">49</a></sup>. More studies are required to define which of these agents, and in which combinations, lead to infection-free clinical benefit.</p></div><div class=section><a name=d95813e593 class=n-a></a><h3 class=section-title>Adjunctive therapy</h3><p class="" id=d95813e598>Whilst antimicrobial<sup><a href="#ref-50">50</a>,<a href="#ref-51">51</a></sup> prophylaxis, with immunosuppression as required remains the mandatory treatment for patients with CGD, and in many centres, IFNγ prophylaxis<sup><a href="#ref-52">52</a></sup>, nevertheless, adjunct therapies are sometimes required to treat refractory infection.</p><p class="" id=d95813e612>Pioglitazone is a peroxisome proliferator–activated receptor gamma (PPARγ) agonist used in the treatment of type 2 diabetes. A recent study demonstrates that, in murine models and human cells, pioglitazone enhanced stimulated mitochondrial-derived ROS production in neutrophils and monocytes from blood and neutrophils and inflammatory macrophages recruited to tissues and thus represents a possible new treatment strategy in CGD patients with severe infection<sup><a href="#ref-53">53</a></sup>.</p><p class="" id=d95813e619>The value of granulocyte infusions to treat such infections remains controversial and there are no trial data to demonstrate efficacy, although case reports suggest efficacy in treating serious bacterial and fungal infections<sup><a href="#ref-54">54</a></sup>. A retrospective study of 69 infusion courses in 48 patients in a non-transplant setting reports on the outcome over a 29-year period<sup><a href="#ref-55">55</a></sup>. More than 80% of infections improved. Best results seen when infusions were started early in the disease course, and when higher numbers of infusions were administered, irrespective of disease genotype, infection site or causative agent. Adverse events—including fever, rigors, flushing, vomiting, irritability, or agitation, and, in two patients, transient dyspnoea—were reported in less than 2% of 1594 individual infusions. Significantly, 16 patients developed allo-immunisation. This study demonstrates that this treatment approach is generally safe and has utility, although sourcing granulocytes can be difficult, and for those patients in whom stem cell transplantation is an option, allo-immunisation may complicate subsequent treatment.</p><p class="" id=d95813e630>The utility of thoracic surgery in patients with severe pulmonary infection is reported<sup><a href="#ref-56">56</a></sup>. The outcome of 51 thoracic procedures in 35 patients over a 25-year period was documented. The 90-day mortality was 6%, and 37% of patients had died by the time of analysis, predominantly from pulmonary infection. Poor prognostic features were chest wall resection or significant intra-operative blood loss. Patients requiring thoracic surgery are high-risk and, following surgery, should be considered for definitive treatment.</p></div><div class=section><a name=d95813e638 class=n-a></a><h3 class=section-title>Haematopoietic stem cell transplantation</h3><p class="" id=d95813e643>To date, haematopoietic stem cell transplantation remains the only definitive curative treatment. Numerous studies have shown efficacy, and an improvement in survival, most notably that reported by Güngör and colleagues using a targeted sub-myelo-ablative busulfan conditioning regimen<sup><a href="#ref-57">57</a></sup>. Now results of a multi-centre study using a treosulfan stem are reported<sup><a href="#ref-58">58</a></sup>. Treosulfan-based regimens are myelo-ablative but associated with a low toxicity profile. Seventy paediatric patients from 16 centres worldwide were transplanted between 2006 and 2015, the majority with features associated with poor transplant outcomes. No major treatment-related toxicities were reported. The overall survival was 91.4%, and event-free survival was 81.4% at a median follow-up of 34 months, and there was a low cumulative incidence of acute grade III-IV graft-versus-host disease (12%). Complete myeloid donor chimerism was documented in 80% of surviving patients. However, secondary graft failure occurred in 12% of patients. This study demonstrates that treosulfan-containing conditioning regimens can be used safely for children with CGD and high-risk clinical features, achieving an excellent survival and high percentage of complete myeloid chimerism. Further studies are required to compare this regimen with others, particularly to evaluate the long-term outcome, particularly regarding durability of myeloid chimerism and fertility.</p><p class="" id=d95813e654>Novel methods of T-lymphocyte depletion are increasingly used as treatment for patients without HLA-matched stem cell donors. The method most commonly reported to date in patients with primary immunodeficiency uses an organic iron bead attached to an antibody to remove CD3 TCRαβ and CD19<sup>+</sup> lymphocytes <i>ex vivo</i> from the other cells by passing the haematopoietic stem cell source through a magnetic column<sup><a href="#ref-59">59</a>–<a href="#ref-60">61</a></sup>. From these series, four patients with CGD were transplanted successfully; one rejected the graft, most likely because of inadequate conditioning, but was successfully re-transplanted. High-dose post-transplant cyclophosphamide has been used to treat malignant and non-malignant disease. One patient with X-linked CGD has been successfully treated with this method using a haploidentical donor. Despite active <i>Scedosporium apiospermum</i> infection and development of grade 2 graft-versus-host disease, the patient was well at 9 months of follow-up<sup><a href="#ref-62">62</a></sup>.</p></div><div class=section><a name=d95813e678 class=n-a></a><h3 class=section-title>Gene therapy</h3><p class="" id=d95813e683>Modification of germline DNA to correct mutated genes is a natural treatment progression from replacement of defective recipient haematopoietic stem cells with normal allogeneic donor cells. Initial gene addition trials using gamma-retroviral vectors to treat X-linked CGD achieved limited gene transduction, resulting in low levels of functional protein. Nevertheless, patients were able to clear persistent life-threatening fungal infection and receive significant clinical benefit. However, whilst methylation of the long terminal repeat (LTR) promoter elements led to gene expression silencing and disappearance of functional neutrophils, the intact enhancer activity of the viral vector drove transactivation of proto-oncogenes, leading to myelodysplasia in three patients<sup><a href="#ref-63">63</a></sup>. Multi-centre clinical trials using a new self-inactivating lentiviral vector are in progress, but no results have been published to date.</p><p class="" id=d95813e690>Rapid developments in methods of integrating viral vectors into ‘safe’ genomic regions to reduce risks of ‘off-target’ effects and in methodsof gene editing have been recently reported. Two groups have demonstrated targeted insertion of a gp91<sup>phox</sup> construct into safe genomic regions. An electroporated zinc finger nuclease mRNA and adeno-associated virus 6 delivery of donor constructs into human haematopoietic stem cells demonstrated significant levels of targeted integration into a safe harbour locus<sup><a href="#ref-64">64</a></sup>, with almost clinically relevant levels of gp91<sup>phox</sup> expression and increased NOX activity in <i>in vitro</i>–derived neutrophils. A second group used transcription activator-like effector nucleases (TALENs) to insert a myelo-specific gp91<sup>phox</sup> cassette into patient-derived induced pluripotent stem cells (iPSCs) and demonstrated restored ROS production from corrected X-CGD iPSC-derived granulocytes that induced NET formation<sup><a href="#ref-65">65</a></sup>. Targeted insertion of an exon 2–13 minigene into exon 2 of <i>CYBB</i> resulted in normal regulation of gp91<sup>phox</sup> expression by the endogenous <i>CYBB</i> promoter and restored gp91<sup>phox</sup> and NOX activity, demonstrating the necessity of retention of intronic elements for expression of the minigene<sup><a href="#ref-66">66</a></sup>. CRISPR-Cas9 correction of <i>CYBB</i><sup><a href="#ref-67">67</a></sup> and <i>NCF1</i><sup><a href="#ref-68">68</a></sup> has also been demonstrated recently. Finally, a zinc finger nuclease has been used to correct the GT deletion at the start of exon 2 in an NCF1 pseudogene and demonstrate restoration of function<sup><a href="#ref-69">69</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d95813e751>Conclusions</h2><p class="" id=d95813e754>The last few years have seen tremendous advances in our knowledge of CGD. The problems experienced by X-linked carriers, specifically a lupus-like disorder or other autoimmune manifestations and fatigue, have been over-looked, and many would benefit from focussed medical care. The rapid progress in gene therapy is extremely exciting, and clinical trials using gene-editing techniques are likely to be developed within the next 5 years. In the meantime, haematopoietic stem cell transplantation is safe, even for patients with severe infection or inflammation, and stem cell manipulation techniques should mean that a suitable donor is available for every patient.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d95813e760>Abbreviations</h2><p class="" id=d95813e763>AR, autosomal recessive; BCG, Bacillus Calmette–Guérin; CGD, chronic granulomatous disease; HLH, haemophagocytic lymphohistiocytosis; IFN, interferon; IL, interleukin; iPSC, induced pluripotent stem cell; NADPH, nicotinamide adenine dinucleotide phosphate; NET, neutrophil extracellular trap; NIH, National Institutes of Health; NOX, nicotinamide adenine dinucleotide phosphate oxidase; ROS, reactive oxygen species; SLE, systemic lupus erythematosus; TNFα, tumour necrosis factor alpha.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d95813e1 class=n-a></a><h2 class=main-title id=d96067>Competing interests</h2><p class=metadata-entry><a name=d95813e84 class=n-a></a><p id=d95813e86> The author declares that he has no competing interests.</p></p></div><div class=back-section><a name=d95813e1 class=n-a></a><h2 class=main-title id=d96069>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d95813e770 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d96293>References</h2><div class="section ref-list"><a name=d95813e770 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d95813e777 class=n-a></a>Berendes H, Bridges RA, Good RA: A fatal granulomatosus of childhood: the clinical study of a new syndrome. <i>Minn Med.</i> 1957; <b>40</b>(5): 309–12. <a target=xrefwindow id=d95813e785 href="http://www.ncbi.nlm.nih.gov/pubmed/13430573">PubMed Abstract </a> | <a target=xrefwindow id=d95813e788 href="http://dx.doi.org/10.1001/archpedi.1959.02070010389004">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d95813e797 class=n-a></a>Jones LB, McGrogan KR, Flood TJ, <i> et al.</i>: Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. <i>Clin Exp Immunol.</i> 2008; <b>152</b>(2): 211–8. <a target=xrefwindow id=d95813e808 href="http://www.ncbi.nlm.nih.gov/pubmed/18410635">PubMed Abstract </a> | <a target=xrefwindow id=d95813e811 href="http://dx.doi.org/10.1111/j.1365-2249.2008.03644.x">Publisher Full Text </a> | <a target=xrefwindow id=d95813e815 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2384093">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d95813e824 class=n-a></a>Segal BH, Leto TL, Gallin JI, <i> et al.</i>: Genetic, biochemical, and clinical features of chronic granulomatous disease. <i>Medicine (Baltimore).</i> 2000; <b>79</b>(3): 170–200. <a target=xrefwindow id=d95813e835 href="http://www.ncbi.nlm.nih.gov/pubmed/10844936">PubMed Abstract </a> | <a target=xrefwindow id=d95813e838 href="http://dx.doi.org/10.1097/00005792-200005000-00004">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d95813e847 class=n-a></a>Mouy R, Fischer A, Vilmer E, <i> et al.</i>: Incidence, severity, and prevention of infections in chronic granulomatous disease. <i>J Pediatr.</i> 1989; <b>114</b>(4 Pt 1): 555–60. <a target=xrefwindow id=d95813e858 href="http://www.ncbi.nlm.nih.gov/pubmed/2784499">PubMed Abstract </a> | <a target=xrefwindow id=d95813e861 href="http://dx.doi.org/10.1016/S0022-3476(89)80693-6">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d95813e870 class=n-a></a>Ahlin A, De Boer M, Roos D, <i> et al.</i>: Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. <i>Acta Paediatr.</i> 1995; <b>84</b>(12): 1386–94. <a target=xrefwindow id=d95813e881 href="http://www.ncbi.nlm.nih.gov/pubmed/8645957">PubMed Abstract </a> | <a target=xrefwindow id=d95813e884 href="http://dx.doi.org/10.1111/j.1651-2227.1995.tb13575.x">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d95813e894 class=n-a></a>Winkelstein JA, Marino MC, Johnston RB Jr, <i> et al.</i>: Chronic granulomatous disease. Report on a national registry of 368 patients. <i>Medicine (Baltimore).</i> 2000; <b>79</b>(3): 155–69. <a target=xrefwindow id=d95813e905 href="http://www.ncbi.nlm.nih.gov/pubmed/10844935">PubMed Abstract </a> | <a target=xrefwindow id=d95813e908 href="http://dx.doi.org/10.1097/00005792-200005000-00003">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d95813e917 class=n-a></a>Martire B, Rondelli R, Soresina A, <i> et al.</i>: Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. <i>Clin Immunol.</i> 2008; <b>126</b>(2): 155–64. <a target=xrefwindow id=d95813e928 href="http://www.ncbi.nlm.nih.gov/pubmed/18037347">PubMed Abstract </a> | <a target=xrefwindow id=d95813e931 href="http://dx.doi.org/10.1016/j.clim.2007.09.008">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d95813e940 class=n-a></a>van den Berg JM, van Koppen E, Ahlin A, <i> et al.</i>: Chronic granulomatous disease: the European experience. <i>PLoS One.</i> 2009; <b>4</b>(4): e5234. <a target=xrefwindow id=d95813e951 href="http://www.ncbi.nlm.nih.gov/pubmed/19381301">PubMed Abstract </a> | <a target=xrefwindow id=d95813e954 href="http://dx.doi.org/10.1371/journal.pone.0005234">Publisher Full Text </a> | <a target=xrefwindow id=d95813e958 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2668749">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d95813e967 class=n-a></a>Cole T, McKendrick F, Titman P, <i> et al.</i>: Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant. <i>J Clin Immunol.</i> 2013; <b>33</b>(1): 8–13. <a target=xrefwindow id=d95813e978 href="http://www.ncbi.nlm.nih.gov/pubmed/23011479">PubMed Abstract </a> | <a target=xrefwindow id=d95813e981 href="http://dx.doi.org/10.1007/s10875-012-9758-0">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727861403"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e990 class=n-a></a>Wu J, Wang WF, Zhang YD, <i> et al.</i>: Clinical Features and Genetic Analysis of 48 Patients with Chronic Granulomatous Disease in a Single Center Study from Shanghai, China (2005-2015): New Studies and a Literature Review. <i>J Immunol Res.</i> 2017; <b>2017</b>: 8745254. <a target=xrefwindow id=d95813e1001 href="http://www.ncbi.nlm.nih.gov/pubmed/28251166">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1004 href="http://dx.doi.org/10.1155/2017/8745254">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1008 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5303869">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727861403">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d95813e1021 class=n-a></a>Xu H, Tian W, Li SJ, <i> et al.</i>: Clinical and molecular features of 38 children with chronic granulomatous disease in mainland china. <i>J Clin Immunol.</i> 2014; <b>34</b>(6): 633–41. <a target=xrefwindow id=d95813e1032 href="http://www.ncbi.nlm.nih.gov/pubmed/24943880">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1035 href="http://dx.doi.org/10.1007/s10875-014-0061-0">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d95813e1045 class=n-a></a>Roos D: Comments on J Clin Immunol (2014) 34:633–641 DOI 10.1007/s10875-014-0061-0. Clinical and Molecular Findings of 38 Children with Chronic Granulomatous Disease in Mainland China, by Huan Xu et al. <i>J Clin Immunol.</i> 2017; <b>37</b>(1): 3–4. <a target=xrefwindow id=d95813e1053 href="http://dx.doi.org/10.1007/s10875-016-0329-7">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727453869"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1062 class=n-a></a>Rawat A, Vignesh P, Sharma A, <i> et al.</i>: Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India. <i>J Clin Immunol.</i> 2017; <b>37</b>(3): 319–28. <a target=xrefwindow id=d95813e1073 href="http://www.ncbi.nlm.nih.gov/pubmed/28332028">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1076 href="http://dx.doi.org/10.1007/s10875-017-0382-x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727453869">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726821238"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1089 class=n-a></a>Kulkarni M, Desai M, Gupta M, <i> et al.</i>: Clinical, Immunological, and Molecular Findings of Patients with p47<sup>phox</sup> Defect Chronic Granulomatous Disease (CGD) in Indian Families. <i>J Clin Immunol.</i> 2016; <b>36</b>(8): 774–84. <a target=xrefwindow id=d95813e1103 href="http://www.ncbi.nlm.nih.gov/pubmed/27699571">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1107 href="http://dx.doi.org/10.1007/s10875-016-0333-y">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726821238">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726379683"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1120 class=n-a></a>El Hawary R, Meshaal S, Deswarte C, <i> et al.</i>: Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience. <i>J Clin Immunol.</i> 2016; <b>36</b>(6): 610–8. <a target=xrefwindow id=d95813e1131 href="http://www.ncbi.nlm.nih.gov/pubmed/27222152">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1134 href="http://dx.doi.org/10.1007/s10875-016-0297-y">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726379683">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726379704"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1147 class=n-a></a>Ben-Farhat K, Ben-Mustapha I, Ben-Ali M, <i> et al.</i>: A Founder Effect of c.257 + 2T &gt; C Mutation in <i>NCF2</i> Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients. <i>J Clin Immunol.</i> 2016; <b>36</b>: 547–54. <a target=xrefwindow id=d95813e1161 href="http://www.ncbi.nlm.nih.gov/pubmed/27220316">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1165 href="http://dx.doi.org/10.1007/s10875-016-0299-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726379704">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d95813e1178 class=n-a></a>Al-Zadjali S, Al-Tamemi S, Elnour I, <i> et al.</i>: Clinical and molecular findings of chronic granulomatous disease in Oman: family studies. <i>Clin Genet.</i> 2015; <b>87</b>(2): 185–9. <a target=xrefwindow id=d95813e1189 href="http://www.ncbi.nlm.nih.gov/pubmed/24446915">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1192 href="http://dx.doi.org/10.1111/cge.12351">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d95813e1202 class=n-a></a>Kim YM, Park JE, Kim JY, <i> et al.</i>: Genetic analysis of 10 unrelated Korean families with p22-phox-deficient chronic granulomatous disease: an unusually identical mutation of the CYBA gene on Jeju Island, Korea. <i>J Korean Med Sci.</i> 2009; <b>24</b>(6): 1045–50. <a target=xrefwindow id=d95813e1213 href="http://www.ncbi.nlm.nih.gov/pubmed/19949658">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1216 href="http://dx.doi.org/10.3346/jkms.2009.24.6.1045">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1220 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2775850">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d95813e1229 class=n-a></a>de Boer M, Tzur S, van Leeuwen K, <i> et al.</i>: A founder effect for p47<sup>phox</sup> <i>Trp193Ter</i> chronic granulomatous disease in Kavkazi Jews. <i>Blood Cells Mol Dis.</i> 2015; <b>55</b>(4): 320–7. <a target=xrefwindow id=d95813e1247 href="http://www.ncbi.nlm.nih.gov/pubmed/26460255">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1250 href="http://dx.doi.org/10.1016/j.bcmd.2015.07.014">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726820730"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1259 class=n-a></a>Wolach B, Gavrieli R, de Boer M, <i> et al.</i>: Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients. <i>Am J Hematol.</i> 2017; <b>92</b>(1): 28–36. <a target=xrefwindow id=d95813e1270 href="http://www.ncbi.nlm.nih.gov/pubmed/27701760">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1273 href="http://dx.doi.org/10.1002/ajh.24573">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726820730">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8479958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1286 class=n-a></a>Kuhns DB, Alvord WG, Heller T, <i> et al.</i>: Residual NADPH oxidase and survival in chronic granulomatous disease. <i>N Engl J Med.</i> 2010; <b>363</b>(27): 2600–10. <a target=xrefwindow id=d95813e1297 href="http://www.ncbi.nlm.nih.gov/pubmed/21190454">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1300 href="http://dx.doi.org/10.1056/NEJMoa1007097">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1304 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3069846">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8479958">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726043039"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1317 class=n-a></a>Lugo Reyes SO, Ramirez-Vazquez G, Cruz Hernández A, <i> et al.</i>: Clinical Features, Non-Infectious Manifestations and Survival Analysis of 161 Children with Primary Immunodeficiency in Mexico: A Single Center Experience Over two Decades. <i>J Clin Immunol.</i> 2016; <b>36</b>(1): 56–65. <a target=xrefwindow id=d95813e1328 href="http://www.ncbi.nlm.nih.gov/pubmed/26707787">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1331 href="http://dx.doi.org/10.1007/s10875-015-0226-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726043039">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725649229"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1344 class=n-a></a>de Oliveira-Junior EB, Zurro NB, Prando C, <i> et al.</i>: Clinical and Genotypic Spectrum of Chronic Granulomatous Disease in 71 Latin American Patients: First Report from the LASID Registry. <i>Pediatr Blood Cancer.</i> 2015; <b>62</b>(12): 2101–7. <a target=xrefwindow id=d95813e1355 href="http://www.ncbi.nlm.nih.gov/pubmed/26185101">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1358 href="http://dx.doi.org/10.1002/pbc.25674">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725649229">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726190648"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1372 class=n-a></a>Conti F, Lugo-Reyes SO, Blancas Galicia L, <i> et al.</i>: Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. <i>J Allergy Clin Immunol.</i> 2016; <b>138</b>(1): 241–248.e3. <a target=xrefwindow id=d95813e1383 href="http://www.ncbi.nlm.nih.gov/pubmed/26936803">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1386 href="http://dx.doi.org/10.1016/j.jaci.2015.11.041">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726190648">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727464243"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1399 class=n-a></a>Dunogué B, Pilmis B, Mahlaoui N, <i> et al.</i>: Chronic Granulomatous Disease in Patients Reaching Adulthood: A Nationwide Study in France. <i>Clin Infect Dis.</i> 2017; <b>64</b>(6): 767–75. <a target=xrefwindow id=d95813e1410 href="http://www.ncbi.nlm.nih.gov/pubmed/28362954">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1413 href="http://dx.doi.org/10.1093/cid/ciw837">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727464243">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d95813e1426 class=n-a></a>Liese JG, Jendrossek V, Jansson A, <i> et al.</i>: Chronic granulomatous disease in adults. <i>Lancet.</i> 1996; <b>347</b>(8996): 220–3. <a target=xrefwindow id=d95813e1437 href="http://www.ncbi.nlm.nih.gov/pubmed/8551880">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1440 href="http://dx.doi.org/10.1016/S0140-6736(96)90403-1">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725324760"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1449 class=n-a></a>Salvator H, Mahlaoui N, Catherinot E, <i> et al.</i>: Pulmonary manifestations in adult patients with chronic granulomatous disease. <i>Eur Respir J.</i> 2015; <b>45</b>(6): 1613–23. <a target=xrefwindow id=d95813e1460 href="http://www.ncbi.nlm.nih.gov/pubmed/25614174">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1463 href="http://dx.doi.org/10.1183/09031936.00118414">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725324760">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727398818"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1476 class=n-a></a>Colin de Verdière S, Noel E, Lozano C, <i> et al.</i>: Respiratory Complications Lead to the Diagnosis of Chronic Granulomatous Disease in Two Adult Patients. <i>J Clin Immunol.</i> 2017; <b>37</b>(2): 113–6. <a target=xrefwindow id=d95813e1487 href="http://www.ncbi.nlm.nih.gov/pubmed/28130637">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1490 href="http://dx.doi.org/10.1007/s10875-017-0370-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727398818">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d95813e1503 class=n-a></a>Tabarsi P, Mirsaeidi M, Karimi S, <i> et al.</i>: Lymphocytic bronchiolitis as presenting disorder in an undiagnosed adult patient with chronic granulomatous disease. <i>Iran J Allergy Asthma Immunol.</i> 2007; <b>6</b>(4): 219–21. <a target=xrefwindow id=d95813e1514 href="http://www.ncbi.nlm.nih.gov/pubmed/18094446">PubMed Abstract </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d95813e1524 class=n-a></a>Klebanoff SJ, White LR: Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood. <i>N Engl J Med.</i> 1969; <b>280</b>(9): 460–6. <a target=xrefwindow id=d95813e1532 href="http://www.ncbi.nlm.nih.gov/pubmed/4974160">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1535 href="http://dx.doi.org/10.1056/NEJM196902272800902">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d95813e1544 class=n-a></a>Sibley CT, Estwick T, Zavodni A, <i> et al.</i>: Assessment of atherosclerosis in chronic granulomatous disease. <i>Circulation.</i> 2014; <b>130</b>(23): 2031–9. <a target=xrefwindow id=d95813e1555 href="http://www.ncbi.nlm.nih.gov/pubmed/25239440">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1558 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.113.006824">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1562 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4258873">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726943182"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1571 class=n-a></a>Huang C, De Ravin SS, Paul AR, <i> et al.</i>: Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease. <i>Inflamm Bowel Dis.</i> 2016; <b>22</b>(12): 2794–801. <a target=xrefwindow id=d95813e1582 href="http://www.ncbi.nlm.nih.gov/pubmed/27861181">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1585 href="http://dx.doi.org/10.1097/MIB.0000000000000966">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1589 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5303573">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726943182">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725959990"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1602 class=n-a></a>Broides A, Sagi O, Pinsk V, <i> et al.</i>: Subclinical intestinal inflammation in chronic granulomatous disease patients. <i>Immunol Res.</i> 2016; <b>64</b>(1): 155–9. <a target=xrefwindow id=d95813e1613 href="http://www.ncbi.nlm.nih.gov/pubmed/26603166">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1616 href="http://dx.doi.org/10.1007/s12026-015-8733-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725959990">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725918982"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1629 class=n-a></a>Khangura SK, Kamal N, Ho N, <i> et al.</i>: Gastrointestinal Features of Chronic Granulomatous Disease Found During Endoscopy. <i>Clin Gastroenterol Hepatol.</i> 2016; <b>14</b>(3): 395–402.e5. <a target=xrefwindow id=d95813e1640 href="http://www.ncbi.nlm.nih.gov/pubmed/26545803">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1643 href="http://dx.doi.org/10.1016/j.cgh.2015.10.030">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725918982">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726266356"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1656 class=n-a></a>Falcone EL, Abusleme L, Swamydas M, <i> et al.</i>: Colitis susceptibility in p47<sup><i>phox-/-</i></sup> mice is mediated by the microbiome. <i>Microbiome.</i> 2016; <b>4</b>: 13. <a target=xrefwindow id=d95813e1671 href="http://www.ncbi.nlm.nih.gov/pubmed/27044504">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1675 href="http://dx.doi.org/10.1186/s40168-016-0159-0">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1678 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4820915">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726266356">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726082233"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1692 class=n-a></a>Lood C, Blanco LP, Purmalek MM, <i> et al.</i>: Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. <i>Nat Med.</i> 2016; <b>22</b>(2): 146–53. <a target=xrefwindow id=d95813e1703 href="http://www.ncbi.nlm.nih.gov/pubmed/26779811">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1706 href="http://dx.doi.org/10.1038/nm.4027">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1710 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4742415">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726082233">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726132294"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1723 class=n-a></a>Weisser M, Demel UM, Stein S, <i> et al.</i>: Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions. <i>J Allergy Clin Immunol.</i> 2016; <b>138</b>(1): 219–228.e9. <a target=xrefwindow id=d95813e1734 href="http://www.ncbi.nlm.nih.gov/pubmed/26853280">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1737 href="http://dx.doi.org/10.1016/j.jaci.2015.11.028">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726132294">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d95813e1750 class=n-a></a>Bode SF, Ammann S, Al-Herz W, <i> et al.</i>: The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. <i>Haematologica.</i> 2015; <b>100</b>(7): 978–88. <a target=xrefwindow id=d95813e1761 href="http://www.ncbi.nlm.nih.gov/pubmed/26022711">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1764 href="http://dx.doi.org/10.3324/haematol.2014.121608">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1768 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4486233">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d95813e1777 class=n-a></a>Brandrup F, Koch C, Petri M, <i> et al.</i>: Discoid lupus erythematosus-like lesions and stomatitis in female carriers of X-linked chronic granulomatous disease. <i>Br J Dermatol.</i> 1981; <b>104</b>(5): 495–505. <a target=xrefwindow id=d95813e1788 href="http://www.ncbi.nlm.nih.gov/pubmed/7236510">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1791 href="http://dx.doi.org/10.1111/j.1365-2133.1981.tb08163.x">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d95813e1800 class=n-a></a>Battersby AC, Braggins H, Pearce MS, <i> et al.</i>: Inflammatory and autoimmune manifestations in X-linked carriers of chronic granulomatous disease in the United Kingdom. <i>J Allergy Clin Immunol.</i> 2017; <b>140</b>(2): 628–630.e6, pii: S0091-6749(17)30428-1. <a target=xrefwindow id=d95813e1811 href="http://www.ncbi.nlm.nih.gov/pubmed/28343844">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1814 href="http://dx.doi.org/10.1016/j.jaci.2017.02.029">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d95813e1823 class=n-a></a>Battersby AC, Martin AJ, Tarn J, <i> et al.</i>: Raised Serum IL-8 Levels Are Associated with Excessive Fatigue in Female Carriers of X-Linked Chronic Granulomatous Disease in the UK. <i>J Clin Immunol.</i> 2017; <b>37</b>(3): 279–81. <a target=xrefwindow id=d95813e1834 href="http://www.ncbi.nlm.nih.gov/pubmed/28337619">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1837 href="http://dx.doi.org/10.1007/s10875-017-0384-8">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727630946"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1847 class=n-a></a>Marciano BE, Zerbe CS, Falcone EL, <i> et al.</i>: X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability. <i>J Allergy Clin Immunol.</i> 2017; pii: S0091-6749(17)30763-7. <a target=xrefwindow id=d95813e1855 href="http://www.ncbi.nlm.nih.gov/pubmed/28528201">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1858 href="http://dx.doi.org/10.1016/j.jaci.2017.04.035">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727630946">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727862318"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e1871 class=n-a></a>Hauck F, Koletzko S, Walz C, <i> et al.</i>: Diagnostic and Treatment Options for Severe IBD in Female X-CGD Carriers with Non-random X-inactivation. <i>J Crohns Colitis.</i> 2016; <b>10</b>(1): 112–5. <a target=xrefwindow id=d95813e1882 href="http://www.ncbi.nlm.nih.gov/pubmed/26464403">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1885 href="http://dx.doi.org/10.1093/ecco-jcc/jjv186">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727862318">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d95813e1898 class=n-a></a>Sarwar G, de Malmanche T, Rassam L, <i> et al.</i>: Chronic granulomatous disease presenting as refractory pneumonia in late adulthood. <i>Respirol Case Rep.</i> 2015; <b>3</b>(2): 54–6. <a target=xrefwindow id=d95813e1909 href="http://www.ncbi.nlm.nih.gov/pubmed/26090111">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1912 href="http://dx.doi.org/10.1002/rcr2.99">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1916 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4469140">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d95813e1925 class=n-a></a>Uzel G, Orange JS, Poliak N, <i> et al.</i>: Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. <i>Clin Infect Dis.</i> 2010; <b>51</b>(12): 1429–34. <a target=xrefwindow id=d95813e1936 href="http://www.ncbi.nlm.nih.gov/pubmed/21058909">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1939 href="http://dx.doi.org/10.1086/657308">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1943 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3106244">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d95813e1952 class=n-a></a>de Luca A, Smeekens SP, Casagrande A, <i> et al.</i>: IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. <i>Proc Natl Acad Sci U S A.</i> 2014; <b>111</b>(9): 3526–31. <a target=xrefwindow id=d95813e1963 href="http://www.ncbi.nlm.nih.gov/pubmed/24550444">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1966 href="http://dx.doi.org/10.1073/pnas.1322831111">Publisher Full Text </a> | <a target=xrefwindow id=d95813e1970 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3948220">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d95813e1979 class=n-a></a>Hahn KJ, Ho N, Yockey L, <i> et al.</i>: Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis. <i>Am J Gastroenterol.</i> 2015; <b>110</b>(6): 938–9. <a target=xrefwindow id=d95813e1990 href="http://www.ncbi.nlm.nih.gov/pubmed/26052777">PubMed Abstract </a> | <a target=xrefwindow id=d95813e1993 href="http://dx.doi.org/10.1038/ajg.2015.135">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726814511"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2003 class=n-a></a>Gabrion A, Hmitou I, Moshous D, <i> et al.</i>: Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease. <i>J Allergy Clin Immunol.</i> 2017; <b>139</b>(5): 1641–1649.e6. <a target=xrefwindow id=d95813e2014 href="http://www.ncbi.nlm.nih.gov/pubmed/27702670">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2017 href="http://dx.doi.org/10.1016/j.jaci.2016.08.033">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726814511">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d95813e2030 class=n-a></a>Butte MJ, Park KT, Lewis DB: Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab. <i>J Clin Immunol.</i> 2016; <b>36</b>(7): 619–20. <a target=xrefwindow id=d95813e2038 href="http://www.ncbi.nlm.nih.gov/pubmed/27465505">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2041 href="http://dx.doi.org/10.1007/s10875-016-0318-x">Publisher Full Text </a> | <a target=xrefwindow id=d95813e2044 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5018915">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d95813e2053 class=n-a></a>Margolis DM, Melnick DA, Alling DW, <i> et al.</i>: Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. <i>J Infect Dis.</i> 1990; <b>162</b>(3): 723–6. <a target=xrefwindow id=d95813e2064 href="http://www.ncbi.nlm.nih.gov/pubmed/2117627">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2067 href="http://dx.doi.org/10.1093/infdis/162.3.723">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d95813e2076 class=n-a></a>Gallin JI, Alling DW, Malech HL, <i> et al.</i>: Itraconazole to prevent fungal infections in chronic granulomatous disease. <i>N Engl J Med.</i> 2003; <b>348</b>(24): 2416–22. <a target=xrefwindow id=d95813e2087 href="http://www.ncbi.nlm.nih.gov/pubmed/12802027">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2090 href="http://dx.doi.org/10.1056/NEJMoa021931">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d95813e2099 class=n-a></a>A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. <i>N Engl J Med.</i> 1991; <b>324</b>(8): 509–16. <a target=xrefwindow id=d95813e2107 href="http://www.ncbi.nlm.nih.gov/pubmed/1846940">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2110 href="http://dx.doi.org/10.1056/NEJM199102213240801">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725276474"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2119 class=n-a></a>Fernandez-Boyanapalli RF, Frasch SC, Thomas SM, <i> et al.</i>: Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease. <i>J Allergy Clin Immunol.</i> 2015; <b>135</b>(2): 517–527.e12. <a target=xrefwindow id=d95813e2130 href="http://www.ncbi.nlm.nih.gov/pubmed/25498313">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2133 href="http://dx.doi.org/10.1016/j.jaci.2014.10.034">Publisher Full Text </a> | <a target=xrefwindow id=d95813e2137 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4331116">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725276474">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d95813e2151 class=n-a></a>Ikincioğullari A, Dogu F, Solaz N, <i> et al.</i>: Granulocyte transfusions in children with chronic granulomatous disease and invasive aspergillosis. <i>Ther Apher Dial.</i> 2005; <b>9</b>(2): 137–41. <a target=xrefwindow id=d95813e2162 href="http://www.ncbi.nlm.nih.gov/pubmed/15828925">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2165 href="http://dx.doi.org/10.1111/j.1774-9987.2005.00227.x">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727862427"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2174 class=n-a></a>Marciano BE, Allen ES, Conry-Cantilena C, <i> et al.</i>: Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: The NIH experience. <i>J Allergy Clin Immunol.</i> 2017; <b>140</b>(2): 622–625, pii: S0091-6749(17)30424-4. <a target=xrefwindow id=d95813e2185 href="http://www.ncbi.nlm.nih.gov/pubmed/28342916">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2188 href="http://dx.doi.org/10.1016/j.jaci.2017.02.026">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727862427">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726621507"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2201 class=n-a></a>Feingold PL, Quadri HS, Steinberg SM, <i> et al.</i>: Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience. <i>J Clin Immunol.</i> 2016; <b>36</b>(7): 677–83. <a target=xrefwindow id=d95813e2212 href="http://www.ncbi.nlm.nih.gov/pubmed/27497975">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2215 href="http://dx.doi.org/10.1007/s10875-016-0319-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726621507">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d95813e2228 class=n-a></a>Güngör T, Teira P, Slatter M, <i> et al.</i>: Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. <i>Lancet.</i> 2014; <b>383</b>(9915): 436–48. <a target=xrefwindow id=d95813e2239 href="http://www.ncbi.nlm.nih.gov/pubmed/24161820">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2242 href="http://dx.doi.org/10.1016/S0140-6736(13)62069-3">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d95813e2251 class=n-a></a>Morillo-Gutierrez B, Beier R, Rao K, <i> et al.</i>: Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. <i>Blood.</i> 2016; <b>128</b>(3): 440–8. <a target=xrefwindow id=d95813e2262 href="http://www.ncbi.nlm.nih.gov/pubmed/27216217">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2265 href="http://dx.doi.org/10.1182/blood-2016-03-704015">Publisher Full Text </a> | <a target=xrefwindow id=d95813e2269 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4957165">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718424113"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2278 class=n-a></a>Bertaina A, Merli P, Rutella S, <i> et al.</i>: HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. <i>Blood.</i> 2014; <b>124</b>(5): 822–6. <a target=xrefwindow id=d95813e2289 href="http://www.ncbi.nlm.nih.gov/pubmed/24869942">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2292 href="http://dx.doi.org/10.1182/blood-2014-03-563817">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718424113">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725670270"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2306 class=n-a></a>Balashov D, Shcherbina A, Maschan M, <i> et al.</i>: Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes. <i>Biol Blood Marrow Transplant.</i> 2015; <b>21</b>(11): 1955–62. <a target=xrefwindow id=d95813e2317 href="http://www.ncbi.nlm.nih.gov/pubmed/26187864">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2320 href="http://dx.doi.org/10.1016/j.bbmt.2015.07.008">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725670270">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d95813e2333 class=n-a></a>Shah RM, Elfeky R, Nademi Z, <i> et al.</i>: HLA-haploidentical and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation after TCRαβ+ and CD19+ cell depletion in Children with Primary Immune Deficiencies: United Kingdom Experience. <i>J Allergy Clin Immunol.</i> (in press). </span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725844640"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2348 class=n-a></a>Parta M, Hilligoss D, Kelly C, <i> et al.</i>: Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report. <i>J Clin Immunol.</i> 2015; <b>35</b>(7): 675–80. <a target=xrefwindow id=d95813e2359 href="http://www.ncbi.nlm.nih.gov/pubmed/26453586">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2362 href="http://dx.doi.org/10.1007/s10875-015-0204-y">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725844640">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1014387"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2375 class=n-a></a>Ott MG, Schmidt M, Schwarzwaelder K, <i> et al.</i>: Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of <i>MDS1-EVI1</i>, <i>PRDM16</i> or <i>SETBP1</i>. <i>Nat Med.</i> 2006; <b>12</b>(4): 401–9. <a target=xrefwindow id=d95813e2396 href="http://www.ncbi.nlm.nih.gov/pubmed/16582916">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2399 href="http://dx.doi.org/10.1038/nm1393">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1014387">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726197613"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2412 class=n-a></a>De Ravin SS, Reik A, Liu PQ, <i> et al.</i>: Targeted gene addition in human CD34<sup>+</sup> hematopoietic cells for correction of X-linked chronic granulomatous disease. <i>Nat Biotechnol.</i> 2016; <b>34</b>(4): 424–9. <a target=xrefwindow id=d95813e2426 href="http://www.ncbi.nlm.nih.gov/pubmed/26950749">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2430 href="http://dx.doi.org/10.1038/nbt.3513">Publisher Full Text </a> | <a target=xrefwindow id=d95813e2433 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4824656">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726197613">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725732722"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2446 class=n-a></a>Dreyer AK, Hoffmann D, Lachmann N, <i> et al.</i>: TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells. <i>Biomaterials.</i> 2015; <b>69</b>: 191–200. <a target=xrefwindow id=d95813e2457 href="http://www.ncbi.nlm.nih.gov/pubmed/26295532">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2460 href="http://dx.doi.org/10.1016/j.biomaterials.2015.07.057">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725732722">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727274518"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2474 class=n-a></a>Sweeney CL, Zou J, Choi U, <i> et al.</i>: Targeted Repair of <i>CYBB</i> in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction. <i>Mol Ther.</i> 2017; <b>25</b>(2): 321–30. <a target=xrefwindow id=d95813e2488 href="http://www.ncbi.nlm.nih.gov/pubmed/28153086">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2492 href="http://dx.doi.org/10.1016/j.ymthe.2016.11.012">Publisher Full Text </a> | <a target=xrefwindow id=d95813e2495 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5368476">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727274518">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727200836"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2508 class=n-a></a>De Ravin SS, Li L, Wu X, <i> et al.</i>: CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease. <i>Sci Transl Med.</i> 2017; <b>9</b>(372): pii: eaah3480. <a target=xrefwindow id=d95813e2519 href="http://www.ncbi.nlm.nih.gov/pubmed/28077679">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2522 href="http://dx.doi.org/10.1126/scitranslmed.aah3480">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727200836">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727397583"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d95813e2535 class=n-a></a>Wrona D, Siler U, Reichenbach J: CRISPR/Cas9-generated p47<sup><i>phox</i></sup>-deficient cell line for Chronic Granulomatous Disease gene therapy vector development. <i>Sci Rep.</i> 2017; <b>7</b>: 44187. <a target=xrefwindow id=d95813e2547 href="http://www.ncbi.nlm.nih.gov/pubmed/28287132">PubMed Abstract </a> | <a target=xrefwindow id=d95813e2550 href="http://dx.doi.org/10.1038/srep44187">Publisher Full Text </a> | <a target=xrefwindow id=d95813e2554 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5347011">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727397583">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d95813e2567 class=n-a></a>Merling RK, Kuhns DB, Sweeney CL, <i> et al.</i>: Gene-edited pseudogene resurrection corrects p47<sup>phox</sup> -deficient chronic granulomatous disease. <i>Blood Adv.</i> 2016; <b>1</b>: 270–8. <a target=xrefwindow id=d95813e2581 href="http://dx.doi.org/10.1182/bloodadvances.2016001214">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 11 Aug 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1427.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1427.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Paediatric Immunology and Haematopoietic Stem Cell Transplantation, Great North Childrens&rsquo; Hospital, Newcastle upon Tyne, UK<br/> <sup>2</sup> Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK<br/> <p> <div class=margin-bottom> Andrew Gennery <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1427/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 11 Aug 2017, 6:1427 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11789.1">https://doi.org/10.12688/f1000research.11789.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Gennery A. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12735 data-id=11789 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11789.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1427/v1/pdf?article_uuid=e51ccc91-44fa-4a35-ac8b-159fe8721cfd" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11789.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Gennery A. Recent advances in understanding and treating chronic granulomatous disease [version 1; peer review: 4 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1427 (<a href="https://doi.org/10.12688/f1000research.11789.1" target=_blank>https://doi.org/10.12688/f1000research.11789.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11789 id=mobile-track-article-signin-11789 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11789?target=/articles/6-1427.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12735 /> <input name=articleId type=hidden value=11789 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Nizar Mahlaoui</strong>, Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades Hospital, University Paris Descartes, France </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> Nizar Mahlaoui and Andrew Gennery have previously collaborated on large multicentre studies for hematopoietic cell transplantation (PMID: 28392333, 25595268) and are both on the board of the European Society for Immunodeficiencies. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Andrea Finocchi</strong>, University of Rome Tor Vergata/Bambino Gesù Children's Hospital, Unit of Immunoinfectivology, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Dirk Roos</strong>, Sanquin Research, The Netherlands </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> Andrew Gennery wrote two chapters for a book edited by Dirk Roos (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>John Gallin</strong>, National Institutes of Health, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 11 Aug 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1427.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1427.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25044-24941></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25047-24944></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25045-24942></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25046-24943></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1427/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>11 Aug 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Nizar Mahlaoui</strong>, Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades Hospital, University Paris Descartes, France </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> Nizar Mahlaoui and Andrew Gennery have previously collaborated on large multicentre studies for hematopoietic cell transplantation (PMID: 28392333, 25595268) and are both on the board of the European Society for Immunodeficiencies. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Andrea Finocchi</strong>, University of Rome Tor Vergata/Bambino Gesù Children's Hospital, Unit of Immunoinfectivology, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Dirk Roos</strong>, Sanquin Research, The Netherlands </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> Andrew Gennery wrote two chapters for a book edited by Dirk Roos </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>John Gallin</strong>, National Institutes of Health, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1427.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1427/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding and treating...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1427/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1427/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1427/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Gennery A');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1427/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1427",
            templates : {
                twitter : "Recent advances in understanding and treating chronic granulomatous.... Gennery A, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1427/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding and treating chronic granulomatous disease", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding and treating chronic granulomatous disease", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11789/12735")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12735");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "24944": 0,
                           "24941": 0,
                           "24942": 0,
                           "24943": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "d3946920-c561-4e63-99bf-688213e457a7";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1427.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1427.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1427.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1427.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1427.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>